Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Asmann

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Brain Pathology (Zurich, Switzerland)|March 12, 2021
Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficitsRosa Rademakers, Alexandra M Nicholson, Yingxue Ren, et al.
Leukemia|October 14, 2024
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)Hongwei Tang, Huihuang Yan, Suganti Shivaram, et al.
Acta Neuropathologica|June 6, 2025
Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicingJúlia Faura, Bavo Heeman, Cyril Pottier, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCLKerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Scientific Data|October 12, 2016
Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseasesMariet Allen, Minerva M Carrasquillo, Cory Funk, et al.
Blood Cancer Journal|June 20, 2024
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCLKerstin Wenzl, Matthew E Stokes, Joseph P Novak, et al.
Human Molecular Genetics|October 11, 2019
Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathwaysGeffen Kleinstern, Huihuang Yan, Michelle A T Hildebrandt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor ConditionsFrancesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
Plos Genetics|February 20, 2014
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinomaMitesh J Borad, Mia D Champion, Jan B Egan, et al.
Molecular Neurodegeneration|July 6, 2025
Methylome analysis of FTLD patients with TDP-43 pathology identifies epigenetic signatures specific to pathological subtypesCristina T Vicente, Tejasvi Niranjan, Elise Coopman, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Brain Pathology (Zurich, Switzerland)|March 12, 2021
Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficitsRosa Rademakers, Alexandra M Nicholson, Yingxue Ren, et al.
Leukemia|October 14, 2024
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)Hongwei Tang, Huihuang Yan, Suganti Shivaram, et al.
Acta Neuropathologica|June 6, 2025
Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicingJúlia Faura, Bavo Heeman, Cyril Pottier, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCLKerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Scientific Data|October 12, 2016
Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseasesMariet Allen, Minerva M Carrasquillo, Cory Funk, et al.
Blood Cancer Journal|June 20, 2024
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCLKerstin Wenzl, Matthew E Stokes, Joseph P Novak, et al.
Human Molecular Genetics|October 11, 2019
Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathwaysGeffen Kleinstern, Huihuang Yan, Michelle A T Hildebrandt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor ConditionsFrancesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
Plos Genetics|February 20, 2014
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinomaMitesh J Borad, Mia D Champion, Jan B Egan, et al.
Molecular Neurodegeneration|July 6, 2025
Methylome analysis of FTLD patients with TDP-43 pathology identifies epigenetic signatures specific to pathological subtypesCristina T Vicente, Tejasvi Niranjan, Elise Coopman, et al.
Pageof 4